The Federal Register published notice 99-24595, attributed to FDA and its parent HHS department, on 1999-09-22. Its official title is “Wallace Laboratories et al.; Withdrawal of Approval of 18 New Drug Applications and 44 Abbreviated New Drug Applications,” and PeptideScanner's exact reviewed identity mapping connects the document to Teriparatide.